MarketCapTrends
BIIB

Biogen Inc. (BIIB)

NASDAQ · Healthcare

Biogen Inc. annual/quarterly shareholder equity history from 2008 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • Biogen Inc. shareholder equity for the quarter ending December 31, 2025 were 18.26B, a 9.22% increase year-over-year.
  • Biogen Inc. shareholder equity for 2025 were 18.26B, a 9.22% increase from 2024.
  • Biogen Inc. shareholder equity for 2024 were 16.72B, a 12.95% increase from 2023.
  • Biogen Inc. shareholder equity for 2023 were 14.80B, a 10.46% increase from 2022.
  • Biogen Inc. shareholder equity for 2022 were 13.40B.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Biogen Inc. Annual Shareholder Equity (Millions of US $)
2025$18,257
2024$16,716
2023$14,799
2022$13,398
2021$10,896
2020$10,700
2019$13,343
2018$13,040
2017$12,613
2016$12,140
2015$9,373
2014$10,809
2013$8,620
2012$6,962
2011$6,425
Biogen Inc. Quarterly Shareholder Equity (Millions of US $)
2025-12-31$18,257
2024-12-31$16,716
2023-12-31$14,799
2022-12-31$13,398
2021-12-31$10,896
2020-12-31$10,700
2019-12-31$13,343
2018-12-31$13,040
2017-12-31$12,613
2016-12-31$12,140
2015-12-31$9,373
2014-12-31$10,809
2013-12-31$8,620
2012-12-31$6,962
2011-12-31$6,425
2010-12-31$5,397
2009-12-31$6,222
2008-12-31$5,806

Biogen Inc. Shareholder Equity — FAQ

Biogen Inc. (BIIB) shareholder equity over the last 19 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see BIIB's shareholder equity history?

The chart and table above show Biogen Inc.'s shareholder equity by year and by quarter, including the growth rate.